Enrique Gamez

Dr. Enrique Gamez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SGSara García-Salinas
Sara García-Salinas
MEMichael Evangelopoulos
Michael Evangelopoulos
EGEnrique Gamez
Enrique Gamez
Manuel ArrueboManuel Arruebo
Manuel Arruebo
Silvia IrustaSilvia Irusta
Silvia Irusta
ETEnnio Tasciotti
Ennio Tasciotti

9 April 2024 in Materials
Verified
Journal Article
Open access
PDF file
NINatalia Izquierdo
Natalia Izquierdo
EGEnrique Gamez
Enrique Gamez
TATeresa Alejo
Teresa Alejo
GMGracia Mendoza
Gracia Mendoza
Manuel ArrueboManuel Arruebo
Manuel Arruebo
Herein, we report on the antimicrobial photodynamic effect of polymeric nanoparticles containing the endogenous photosensitizer protoporphyrin IX. Compared to equivalent doses of the free photosensitizer, we demonstrated that the photodynamic antimicrobial efficacy of PLGA (polylactic-co-glycolic acid) nanoparticles containing protoporphyrin IX (PpIX) against pathogenic Staphylococcus aureus (S. aureus) is preserved after encapsulation, while photobleaching is reduced. In addition, compared to equivalent doses of the free porphyrin, we show that a reduction in the cytotoxicity in mammalian cell cultures is observed when encapsulated. Therefore, the encapsulation of protoporphyrin IX reduces its photodegradation, while the released photosensitizer maintains its ability to generate reactive oxygen species upon light irradiation. The polymeric nanoencapsulation promotes aqueous solubility for the hydrophobic PpIX, improves its photostability and reduces the cytotoxicity, while providing an extended release of this endogenous photosensitizer.

1 February 2020 in Molecular Catalysis
Verified
Journal Article
Closed access
MSM. Ángeles Stegmayer
M. Ángeles Stegmayer
VMViviana G. Milt
Viviana G. Milt
NNNuria Navascues
Nuria Navascues
EGEnrique Gamez
Enrique Gamez
SISilvia Irusta
Silvia Irusta
EMEduardo E. Miró
Eduardo E. Miró

2 April 2024 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
CYCristina Yus
Cristina Yus
EGEnrique Gamez
Enrique Gamez
Manuel ArrueboManuel Arruebo
Manuel Arruebo
1. Despite all the awareness campaigns and the active recommended reduction in antibiotic prescriptions and use, antimicrobial resistance remains in the top ten global public health threats for man...

12 October 2025 in Materials Today Chemistry
Verified
Journal Article
Open access
DDDegnet Melese Dereje
Degnet Melese Dereje
Carlotta PontremoliCarlotta Pontremoli
Carlotta Pontremoli
CYCristina Yus
Cristina Yus
EGEnrique Gamez
Enrique Gamez
MPMonica Paesa
Monica Paesa
Nadia BarberoNadia Barbero
Nadia Barbero

9 June 2025 in BMC Chemistry
Verified
Journal Article
Open access
PDF file
SBSara Bescós-Ramo
Sara Bescós-Ramo
EGEnrique Gamez
Enrique Gamez
MEMaría del Mar Encabo-Berzosa
María del Mar Encabo-Berzosa
MPMilagros Piñol
Milagros Piñol
LOLuis Oriol
Luis Oriol
MAManuel Arruebo
Manuel Arruebo
Catechol moieties have been covalently coupled to the last-resort polypeptide antibiotic colistin via esterification and amidation reactions, inspired by the superior antimicrobial action of cefiderocol, i.e., a catechol-substituted siderophore cephalosporin. Among the tested strategies, the incorporation of the catechol motif by amidation reduces by 50% the minimum concentration to inhibit the growth of a clinical strain of uropathogenic Escherichia coli (E. coli) in its planktonic form. Its minimum bactericidal concentration is reduced by 25% after chemical modification. The tested modified antibiotic did not show cytotoxicity against human fibroblasts and keratinocytes at bactericidal doses. Additionally, due to the potential nephrotoxicity of colistin, the cytotoxicity of this catechol-substituted siderophore colistin was evaluated in a 3D model of human renal organoids showing no cytotoxicity at the doses tested. The chemical incorporation of catechol groups to existing antibiotics can reduce the doses to exert a fast antimicrobial action reducing the chances to develop antibiotic resistance.